Replies to post #204631 on Avid Bioservices Inc (CDMO)

[sulaco]

Only in the U.S. does instant gratification take too long


Your list will come, Stone. (with the exception of the BOD change. Don't count on it. They know what they have and they're not showing their poker hand to ANYONE.)

Bavi has great scientific rationale, breast results were super, second-line P2 results were awesome despite the sabotage, and Gabrilovitch loved the liver results, clearly calling for a P3.

Promise me. No. more. tantrums.


Regards,

Joe

[InternetForumUser]

I have always wondered why Peregrine did not hire a respected 3rd Party to review the P2 data after they found the discrepancy. I believe that was a major misstep.

I think a Partnership with a BP would do wonders for the shareholders. Maybe they just finished inking a partnership deal? One can dream.

[purpledawgs]

Stone:

I have been in this stock since 1997. Since that time, I have continued to accumulate and average down. We went through all this same crap when the stock dropped to .39. That was just a few months before things took off until the infamous black Monday. I continually wish I would have made better swing trades on the way up, before riding it back down. But such is the benefit of hindsight.

I continue to believe that PPHM has something that could be very significant in the I/O space. PPHM seems to believe it is worth more than what they can get for an equitable partnership until they get confirmation on the Phase III trial. Right or wrong, that sabotage to the Phase II trial cut deep. Until PPHM can definitively prove the prior results can be duplicated, no BP is going to pay up to what I hope PPHM is demanding in any discussions.

What will a paper on 12 breast patients do for the share price long term? Probably nothing. What will initiating another phase III in breast or liver do in the short term? Probably nothing.
Because we need confirmation on the lung Phase III.

What if potential partners are in the wings waiting for Phase III results to confirm a significant investment? What if they have told PPHM as much? Why would they add board members now? Wouldn't a potential partner want to add their own board members? Then what happens? PPHM would lose a majority on the board.

Something has PPHM confident enough to expand AVID. Something has kept PPHM from having to continually sell a significant amount of ATM shares. Something has the shorts slowly but consistently reducing the shares shorted (by millions of shares). Something has Blackrock continuing to add to its now 12 million shares.

And why do they need a new IB? MLV has been able to place the PPHMP shares so far. What says they can't again if they want/need to place more?

I think they are waiting to get proof on what they believe - that bavi works and the Phase III lung trial will prove it. Then all of the other issues will be fixed almost immediately, just like they were going to be before Black Monday.

I, like everyone else, wish that we had the proof already. But we don't. So we either continue to wait for what we expect will happen - that we repeat the results that showed we dominated the SOC for lung cancer - or we throw in the towel and move on.

It does nothing to complain about the same issues over and over again.

That is my opinion.

pd